Interleukin-21 in cancer immunotherapy: Friend or foe?

OncoImmunology

Volumn 1, Issue 3, 2012, Pages 351-354

  Stolfi, Carmine ^a   Pallone, Francesco ^a   Macdonald, Thomas T ^b   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Colitis associated colon cancer; IL 17A; IL 6; STAT3; Tregs

Indexed keywords

DENENICOKIN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PROTEIN BCL XL; STAT3 PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CANCER RISK; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON CANCER; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENTERITIS; GENE OVEREXPRESSION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; METASTATIC MELANOMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; TRANSCRIPTION INITIATION; ULCERATIVE COLITIS;

EID: 84872387464     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19122     Document Type: Article

References (10)

1. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659:15-30 http://dx.doi.org/10.1016/j.mrrev.2008.03.002
2. Nickoloff BJ, Ben-Neriah Y, Pikarsky E. Inflammation and cancer: is the link as simple as we think? J Invest Dermatol 2005; 124:x-xiv;http://dx.doi.org/10.1111/j.0022-202X.2005.23724.x
3. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-99; http://dx.doi.org/10.1016/j.cell.2010.01.025
4. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006; 25:315-22; http://dx.doi. org/10.1007/s10555-006-9001-7
5. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008; 26:57-79; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090316
6. Søndergaard H, Skak K. IL-21: roles in immunopathology and cancer therapy. Tissue Antigens 2009; 74:467-79; http://dx.doi.org/10.1111/j.1399-0039.2009.01382.x
7. Stolfi C, Rizzo A, Franzè E, Rotondi A, Fantini MC, Sarra M, et al. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 2011; 208:2279-90; http://dx.doi.org/10.1084/jem.20111106
8. Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, et al. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitisassociated tumorigenesis in mice. Gut 2011; 60:1678-86; http://dx.doi.org/10.1136/gutjnl-2011-300612
9. Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010; 138:2101-14.e5; http://dx. doi.org/10.1053/j.gastro.2010.01.058
10. + mice. Cancer Res 2005; 65:3998-4004; http://dx.doi.org/10.1158/0008-5472.CAN-04-3104